1. Introduction {#sec0001}
===============

It is in December 2019 that a new pneumonia, today known as coronavirus disease 2019 or shorlty COVID-19, locally started off in the Chinese city of Wuhan. As of 30 May 2020, the world recorded almost 5.96 million cases of COVID-19 reported worldwide in about 188 countries, nations and territories. Among those reported cases, almost 366,000 people have succumbed to the disease ([Figs. 1](#fig0001){ref-type="fig"} and [8](#fig0008){ref-type="fig"}) but fortunately, almost 2.52 million people have recovered. It is only on 11 March 2020 that the World Health Organization (WHO) declared the COVID-19 a pandemic. Maybe this unprecedented situation, since the 1918 Spanish flu pandemic [@bib0001], would have been different if the alert call from Li Wenliang [@bib0002] was taken into consideration on time by Chinese authorities. Hence, the worldwide epicenter of the disease has since hit several countries, from China to USA via Italy, Spain and UK ( [Fig. 2](#fig0002){ref-type="fig"}, [Fig. 3](#fig0003){ref-type="fig"}, [Fig. 4](#fig0004){ref-type="fig"} and [6](#fig0006){ref-type="fig"}). It has now moved to the southern hemisphere country of Brazil with the winter season ([Fig. 4](#fig0004){ref-type="fig"}).Fig. 1Illustration of Worldwide COVID-19 daily new cases from 21 January to 31 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. We note that the number of infections keep rising meaning that the pandemic is far from being over.Fig. 1Fig. 2Illustration of two former epicenters, China and Italy COVID-19 daily new cases from 21 January to 30 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. We note that the number of infections kept rising until the peak was reached before a decrease. The rise in China was quickly contained, around 16 Feb., before Italy took over the epicenter status until around 21 Mar. 2020.Fig. 2Fig. 3Illustration of two former epicenters, Spain and UK COVID-19 daily new cases from the start of the pandemic (01 march for Spain and 29 March for UK) until 30 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. We note that the number of infections kept rising until the peak was reached before a decrease. The rise in Spain was contained around 1 April 2020, before UK took over the epicenter status around 05 April 2020.Fig. 3Fig. 4Illustration of one former epicenter, USA and the actual epicenter Brazil showing their COVID-19 daily new cases from the start of the pandemic (14 March for Brazil and 24 March for USA) until 30 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. The USA quickly became the new epicenter of the disease around 24 April before starting seing a slight relief around. Though the number of new infections is still high i USA, Brazil has the new epicenter around 27 May 2020.Fig. 4

Highly contagious, COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been proven to spread easily when cold winter conditions are met. In fact, some research made recently [@bib0003] have shown that the SARS-CoV-2 can easily spread in communities that live in places where the temperature is relatively low, around 5 to 11 degrees Celsius, all associated with low specific, of around 3 to 6 *g*/*kg* and absolute humidity of around 4 to 7 *g*/*m* ^3^. As southern hemisphere moves to the winter season, there are worries to feel for two particular countries whose the number of deaths keeps rising: Chile and South Africa ([Figs. 5](#fig0005){ref-type="fig"} and [7](#fig0007){ref-type="fig"} ). More worries for South Africa as the country stands not only as the current most COVID-19 affected country in Africa but also the most HIV affected country. Moreover, the alarming situation in Brazil should be a huge concern for South Africa as both countries face similar precarious social issues as shown in [Table 1](#tbl0001){ref-type="table"} . Recent statistics [@bib0004], [@bib0005] show that COVID-19 mostly kills people with pre-existing diseases such as diabetes, high blood pressure, tuberculosis and also HIV. Hence, this motivated us to study in this paper, a combined HIV-COVID-19 model is order to start another alert call for those concerned countries at risk.Fig. 5Illustration of potential next epicenter: Chile and South Africa COVID-19 daily new cases from the start of the pandemic (16 March for Chile and 18 March for South Africa) until 30 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. It shows that the number of new infections keeps rising in both countries.Fig. 5Fig. 6Worldwide shifting epicenters from China to Brazil and the approximative time they were epicenters. Is Chile or South Africa the next one as they enter the winter season?.Fig. 6Fig. 7Comparative illustration of COVID-19 victims as from 1 June 2020 in all past and current epicenters. We note the global numbers are still relatively low in Chile and South Africa and up-front alerts need to be heard now before it is too late.Fig. 7Fig. 8Illustration of worldwide COVID-19 daily deaths from 21 January to 28 May 2020 according to the WHO Coronavirus disease (COVID-2019) situation reports [@bib0004]. We note that the number of deaths has peaked some times around 29 April 2020 but remain significant in around the world, with exactly 4239 reported on 28 May.Fig. 8Table 1Comparison of some factors [@bib0003], [@bib0006], [@bib0007] favorable to the spread of Covi-19 in Brazil (current epicenter) and South Africa (the potential next).Table 1FAVELLASTOWNSHIPS**Country**BrazilSouth Africa**Approximative population**11 million (6%)14.7 million (25%)(**% of the total population**)**Residents**Mainly African descentsMainly Africans**Characteristics**Poverty, sanitation, water,Poverty, infrastructuregarbage collectionproblems,water supply problempromiscuitydensely populated**COVID-19 state**Most affected in Latin AmericaMost affected in Africa**Feature**The country's presidentThe country's presidentchose not to go for achose to easy the lockdownhard lockdown despite andespite an increasingincreasing number of deathsnumber of deaths

2. A simple COVID-19 model combined to HIV {#sec0002}
==========================================

2.1. A simple HIV-COVID-19 model formulation and assumptions {#sec0003}
------------------------------------------------------------

As commonly done in mathematical epidemiology for other type of diseases [@bib0008], [@bib0009], [@bib0010], [@bib0011], [@bib0012], [@bib0013], [@bib0014], [@bib0015], we start by formulating the model and clarifying the assumptions that will be used throughout. In this section, a simple system modeling the temporal dynamics of the Corona virus (2019-nCov) combined to HIV within human population is described. As we don't have yet all the answers on the real dynamics and spread of the new 2019-nCov, we focus on people who are already COVID-19 infectious (symptomatic or asymptomatic individuals). We assume the people population *N~p~* to be constant and divide it into four different compartments according to their status with respect to the diseases. Hence, at the *t*, we denote by $S_{p} = S_{p}\left( t \right)$ the fraction of the people population that are susceptible, by $I_{c} = I_{c}\left( t \right)$ the fraction of the people population that is COVID-19 only infectious, by $I_{h} = I_{h}\left( t \right)$ the fraction of the people population that is HIV only infectious, by $I_{hc} = I_{hc}\left( t \right)$ the fraction of the people population that is dually infectious with HIV and COVID-19. We assume that the COVID-19 infection process originates from a reservoir or a source of infection (called Ξ) with animals (pangolin or bats, etc) with a total population of $N_{r} = N_{r}\left( t \right)$ that can be divided into two different compartments: The susceptible to COVID-19 ($S_{r} = S_{r}\left( t \right)$) and COVID-19 infectious ($I_{r} = I_{r}\left( t \right)$). We assume that individuals in the susceptible compartment are recruited into the people population at a rate Λ~*p*~ which is constant. Infections with COVID-19 of those individuals happen at a rate of *λ~c~* due to sufficient contact with infected animals in Ξ, and they then move to the compartment of COVID-19 infectious individuals, *I~c~*. Moreover, infections with HIV happen at a rate of *λ~h~* due to sufficient contact with infected individuals and therefore, susceptible individuals move to the compartment of HIV infectious individuals, *I~h~*. People who are infected with COVID-19 only either recover thanks to their own immunity and are moved, at a rate of *γ*, into the compartment of susceptible individuals or are infected with HIV due to sufficient contact with infected individuals, at the fraction rate of ε*λ~h~*, (with ε ∈ (0, 1\]. Recall [@bib0016] that ε is taken as such because we expect an eventual drop of sexual intercourse (principal known cause of HIV transmission) of people who are infected with COVID-19 due to the disease. They then move into the compartment *I~hc~* of dually infectious with HIV and COVID-19. The disease COVID-19 kills people at the rate of *κ~c~*. People who are infected with HIV only either die due to the disease or get the infection with Corona virus, at the rate of *θλ~h~*, due to sufficient contact with infected source. They then move into the compartment *I~hc~* of dually infectious with HIV and COVID-19. Here we take *θ* \> 1 since people infected with HIV have a lower immune system and therefore, are highly susceptible to catch COVID-19. Individuals with both HIV and COVID-19 can recover from COVID-19 thanks to own immunity and are moved, at a rate of ϖ into the compartment of individuals infected with HIV only or die from COVID-19 at the rate of *τκ~c~*. Here we take *τ* \> 1 because of the high probability of mortality within the people in *I~hc~*, with both HIV and COVID-19 compared to individuals infected with COVID-19 only. Furthermore, individuals with both HIV and COVID-19 can also die HIV at a rate of *νκ~h~*. Here we take *ν* ≥ 1 because of the high probability of mortality within the people in *I~hc~*, with both HIV and COVID-19 compared to individuals infected with HIV only. We denote by *μ~h~* the rate at which death due natural causes occurs. We assume that susceptible animals in Ξ, are recruited into the population *N~r~* at a rate of Λ~*r*~ which is constant. We assume that those animals can die the rate of *μ~c~* or can become infected with COVID-19 at a rate of *λ~r~* due to sufficient contact with infected animals and then move to the compartment of COVID-19 infectious *I~r~*. Based on the above setting, the dynamics of the system is given by the transfer diagram as depicted in [Fig. 10](#fig0010){ref-type="fig"} and expressed by the following differential equations:$$\left\{ \begin{array}{l}
{\frac{S_{p}}{dt} = \Lambda_{p} + \gamma I_{c} - \left( \lambda_{c} + \lambda_{h} + \mu_{h} \right)S_{p},} \\
{\frac{I_{c}}{dt} = \lambda_{c}S_{p} - \left( \varepsilon\lambda_{h} + \mu_{h} + \kappa_{c} + \gamma \right)I_{c},} \\
{\frac{I_{h}}{dt} = \lambda_{h}S_{p} + \varpi I_{hc} - \left( \theta\lambda_{c} + \mu_{h} + \kappa_{h} \right)I_{h},} \\
{\frac{I_{hc}}{dt} = \varepsilon\lambda_{h}I_{c} + \theta\lambda_{c}I_{h} - \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)I_{hc},} \\
{\frac{S_{r}}{dt} = \Lambda_{r} - \left( \mu_{c} + \lambda_{r} \right)S_{r}} \\
{\frac{I_{r}}{dt} = \lambda_{r}S_{r} - \mu_{c}I_{r},} \\
\end{array} \right.$$where *λ~c~*, *λ~h~* and *λ~r~* are respectively the forces of infection reading as$$\lambda_{c} = \frac{\beta_{c}\sigma I_{r}}{N_{p}},$$ $$\lambda_{h} = \frac{\beta_{h}\left( I_{h} + \xi_{hc}I_{hc} \right)}{N_{p}},$$ $$\lambda_{r} = \frac{\beta_{r}\sigma I_{r}}{N_{r}},$$with *β~h~* representing the HIV infection effective contact rate, *ξ~hc~* ≥ 1 representing the regularization parameter modeling the relative infectiousness of people with both HIV and COVID-19 (*I~hc~*) compared to individuals infected with HIV only (*I~h~*). For the new corona virus (2019-nCov), *σ* is the per capita vector-to-host contact rate of the animals in the reservoir. *β~c~* is the parameter accounting for the people transmission probability per vector-to-host contact while *β~r~* accounts for the same probability but for animals.Fig. 10Flowdiagram of the HIV-COVID-19 transmission between people and in the reservoir.Fig. 10

3. Sub-model's analysis: Well-posedness, feasibility region and stability {#sec0004}
=========================================================================

In this section we start by analyzing the two sub-models (HIV only and COVID-19 only) contained in the model [(1)](#eq0001){ref-type="disp-formula"}.

4. Sub-model: HIV only {#sec0005}
======================

We establish the HIV only sub-model from model [(1)](#eq0001){ref-type="disp-formula"} by putting $I_{c} = 0,\mspace{6mu} I_{hc} = 0,\mspace{6mu} S_{r} = 0,\mspace{6mu} I_{r} = 0$ which yields$$\left\{ \begin{array}{l}
{\frac{S_{p}}{dt} = \Lambda_{p} - \left( \lambda_{h} + \mu_{h} \right)S_{p},} \\
{\frac{I_{h}}{dt} = \lambda_{h}S_{p} - \left( \mu_{h} + \kappa_{h} \right)I_{h},} \\
\end{array} \right.$$with the force of infection *λ~h~* reading as$$\lambda_{h} = \frac{\beta_{h}I_{h}}{N_{p}},$$where $N_{p} = S_{p} + I_{h}.$ In order analyze the HIV only system [(2)](#eq0002){ref-type="disp-formula"} of human population, we consider the region of biological feasibility given by.$$\Omega_{h} = \left\{ \left( S_{p}\left( t \right),I_{h}\left( t \right) \right) \in \mathbb{R}^{2}:\mspace{6mu} 0 \leq N_{p} = S_{p} + I_{h} \leq \frac{\Lambda_{p}}{\mu_{h}} \right\}.$$we have the following resultsProposition 4.11.*Any solution* (*S~p~*(*t*), *I~h~*(*t*)) *of the HIV only system* [(2)](#eq0002){ref-type="disp-formula"} *remains non-negative for all time t* \> 0 *if the corresponding initial condition is non-negative.*2.*the region* Ω~*h*~ *is positively invariant for the HIV only system* [(2)](#eq0002){ref-type="disp-formula"} *when non-negative initial conditions are taken from* $\mathbb{R}^{2}.$ *In fact it is an attracting and absorbing compact set for the system* [(2)](#eq0002){ref-type="disp-formula"} *.*3.*Moreover, we have* $$\lim\limits_{t\rightarrow\infty}N_{p}\left( t \right) \leq \frac{\Lambda_{p}}{\mu_{h}}.$$ *and* $N_{p}\left( t \right) \leq \frac{\Lambda_{p}}{\mu_{h}}$ *for all t* \> 0 *if* $N_{p}\left( 0 \right) \leq \frac{\Lambda_{p}}{\mu_{h}}.$ ProofThe sum of both equations of [(2)](#eq0002){ref-type="disp-formula"} gives$$\begin{array}{ccl}
\frac{dN_{p}\left( t \right)}{dt} & = & {\frac{dS_{p}\left( t \right)}{dt} + \frac{dI_{h}\left( t \right)}{dt}} \\
 & = & {\Lambda_{p} - \mu_{h}\left( S_{p}\left( t \right) + I_{h}\left( t \right) \right) - \kappa_{h}I_{h}} \\
 & \leq & {\Lambda_{p} - \mu_{h}N_{p}\left( t \right)} \\
\end{array}$$proceeding with standard comparison and integration give$$\begin{array}{ccl}
{N_{p}\left( t \right)} & \leq & {N_{p}\left( 0 \right)\text{e}^{- \mu_{h}t} - \frac{\Lambda_{p}}{\mu_{h}}\text{e}^{- \mu_{h}t}} \\
 & \leq & {\left( N_{h}\left( 0 \right) - \frac{\Lambda_{p}}{\mu_{h}} \right)\text{e}^{- \mu_{h}t} + \frac{\Lambda_{p}}{\mu_{h}}} \\
\end{array}$$Hence we have $N_{p}\left( t \right) \leq \frac{\Lambda_{p}}{\mu_{h}}\mspace{6mu}\text{for}\text{all}\text{time}\mspace{6mu} t \geq 0,$ if $N_{p}\left( 0 \right) - \frac{\Lambda_{p}}{\mu_{h}} \leq 0$ (or $N_{p}\left( 0 \right) \leq \frac{\Lambda_{p}}{\mu_{h}}$). This conclusion also shows the attractiveness and absorbing results for Ω. □

The HIV only system [(2)](#eq0002){ref-type="disp-formula"} can therefore be treated as dynamical system in Ω in which it is well-posed.

4.1. The basic reproduction number $\mathcal{R}_{h}$ {#sec0006}
----------------------------------------------------

The disease-free equilibrium (or the DFE) of the HIV only system [(2)](#eq0002){ref-type="disp-formula"} reads as$$E^{0} = \left( S_{p}^{0},I_{h}^{0} \right)\mspace{6mu}\text{with}\mspace{6mu}\mspace{6mu}\left( S_{p}^{0} = \frac{\Lambda_{p}}{\mu_{h}},I_{h}^{0} = 0 \right).$$Exploiting the next generation operator $FV^{- 1}$ as detailed in [@bib0017] leads to the HIV only system [(2)](#eq0002){ref-type="disp-formula"} written into the matrix form $\overset{˙}{X} = \mathcal{F}\left( X \right) - \mathcal{V}\left( X \right)$ where the matrices $\mathcal{F}$ and $\mathcal{V}$ are respectively given by$$\mathcal{F}\left( X \right) = \begin{pmatrix}
0 \\
{\lambda_{h}\left( t \right)S_{p}\left( t \right)} \\
\end{pmatrix}$$and$$\mathcal{V}\left( X \right) = \begin{pmatrix}
{- \Lambda_{p} + \lambda_{h}\left( t \right)S_{p}\left( t \right) + \mu_{h}S_{p}\left( t \right)} \\
{\mu_{h}I_{h}\left( t \right) + \kappa_{h}I_{h}\left( t \right)} \\
\end{pmatrix}$$Evaluated at the DFE *E* ^0^, the Jacobian of those matrices yields$$F = \left\lbrack \frac{\partial\mathcal{F}_{i}}{\partial x_{j}}\left( E^{0} \right) \right\rbrack = \left( \beta_{h} \right)$$and$$V = \left\lbrack \frac{\partial\mathcal{V}_{i}}{\partial x_{j}}\left( E^{0} \right) \right\rbrack = \left( \mu_{h} + \kappa_{h} \right).$$Hence the basic reproduction number $\mathcal{R}_{h}$ is the spectral radius$$\mathcal{R}_{h} = \rho\left( FV^{- 1} \right) = \frac{\beta_{h}}{\mu_{h} + \kappa_{h}}.$$

4.2. Stability of the DFE *E*^0^ {#sec0007}
--------------------------------

Using the linearization of the HIV only system [(2)](#eq0002){ref-type="disp-formula"} around the DFE *E* ^0^ we obtain the Jacobian matrix reading as$$\left. \mathcal{J} \right|_{E^{0}} = \begin{pmatrix}
{- \mu_{h}} & {- \beta_{h}} \\
0 & {\beta_{h} - \mu_{h} - \kappa_{h}} \\
\end{pmatrix}.$$We easily obtain the eigenvalues $\left. \mathcal{J} \right|_{E^{0}}$ that reads as: $\lambda_{1} = - \mu_{h}$ which is negative and $\lambda_{2} = \beta_{h} - \mu_{h} - \kappa_{h}.$ In terms of $\mathcal{R}_{h},$ we have $\lambda_{2} = \left( \mu_{h} + \kappa_{h} \right)\left( \mathcal{R}_{h} - 1 \right)$. Hence $\left. \lambda_{2} < 0\mspace{6mu}\mspace{6mu}\Longleftrightarrow\mspace{6mu}\mspace{6mu}\mathcal{R}_{h} < 1. \right.$ Thus, we have proven the following resultProposition 4.2*The DFE E* ^0^ *of the model* [(2)](#eq0002){ref-type="disp-formula"} *is locally-asymptotically stable if* $\mathcal{R}_{h} < 1,$ *and unstable if* $\mathcal{R}_{h} > 1.$

For the establishment of global asymptotical stability of the DFE *E* ^0^, we can use the method of Lyapunov-LaSalle by considering a Lyapunov function $L\left( S_{p},I_{h} \right) = \left( \mu_{h} + \kappa_{h} \right)I_{h}.$ Then its time-derivative along a solution (*S~p~*(*t*), *I~h~*(*t*)) reads as$$\begin{array}{ccl}
\frac{dL}{dt} & = & {\left( \mu_{h} + \kappa_{h} \right)\frac{dI_{h}}{dt}} \\
 & = & {\left( \mu_{h} + \kappa_{h} \right)\left( \lambda_{h}S_{p} - \left( \mu_{h} + \kappa_{h} \right)I_{h} \right)} \\
 & = & {\left( \frac{\beta_{h}S_{h}}{N_{p}\left( \mu_{h} + \kappa_{h} \right)} - 1 \right)\frac{\lambda_{h}\left( \mu_{h}^{2} + \kappa_{h}^{2} + 2\mu_{h}\kappa_{h} \right)N_{p}}{\beta_{h}}} \\
 & \leq & {\left( \frac{\beta_{h}}{\left( \mu_{h} + \kappa_{h} \right)} - 1 \right)\frac{\lambda_{h}\left( \mu_{h}^{2} + \kappa_{h}^{2} + 2\mu_{h}\kappa_{h} \right)N_{p}}{\beta_{h}}} \\
 & \leq & {\left( \mathcal{R}_{h} - 1 \right)\frac{\lambda_{h}\left( \mu_{h}^{2} + \kappa_{h}^{2} + 2\mu_{h}\kappa_{h} \right)N_{p}}{\beta_{h}},} \\
\end{array}$$where we have used the fact that $\frac{S_{h}}{N_{p}} \leq 1.$ Hence, knowing that the system parameters are all non-negative, $\frac{dL}{dt} \leq 0$ when $\mathcal{R}_{h} \leq 1.$ Moreover, it happens that $\left. \frac{dL}{dt} = 0\mspace{6mu}\mspace{6mu}\Longleftrightarrow\mspace{6mu}\mspace{6mu} I_{h} = 0. \right.$

Therefore, *L* is a Lyapunov function on Ω~*h*~ and LaSalle's Invariance Principle [@bib0018] implies that all limit points of solutions to the model [(2)](#eq0002){ref-type="disp-formula"} belong to the largest compact invariance set in $\left\{ \left( S_{p}\left( t \right),I_{h}\left( t \right) \right) \in \Omega_{h}:\mspace{6mu}\frac{dL}{dt} = 0 \right\}.$ In that set, $I_{h} = 0$ and $\frac{dS_{p}}{dt} = \Lambda_{p} - \mu_{h}S_{p}$ and thus $\left. S_{p}\longrightarrow\frac{\Lambda_{p}}{\mu_{h}} \right.$ as $\left. t\longrightarrow\infty. \right.$ Thus, Therefore, every solution (*S~p~*(*t*), *I~h~*(*t*)), taking its initial conditions in Ω~*h*~, approaches the DFE $E^{0} = \left( \frac{\Lambda_{p}}{\mu_{h}},0 \right)$ as $\left. t\longrightarrow\infty \right.$ when $\mathcal{R}_{h} \leq 1.$ Henceforth, we have proven the following result:Proposition 4.3*The DFE E* ^0^ *of the model* [(2)](#eq0002){ref-type="disp-formula"} *is globally-asymptotically stable whenever* $\mathcal{R}_{h} \leq 1.$

4.3. Endemic equilibrium {#sec0008}
------------------------

From [(2)](#eq0002){ref-type="disp-formula"} the endemic equilibrium $E^{*} = \left( S_{p}^{*},I_{h}^{*} \right)$ is obtained by solving$$\left\{ \begin{array}{l}
{0 = \Lambda_{p} - \left( \lambda_{h}^{*} + \mu_{h} \right)S_{p}^{*},} \\
{0 = \lambda_{h}^{*}S_{p}^{*} - \left( \mu_{h} + \kappa_{h} \right)I_{h}^{*},} \\
\end{array} \right.$$which yields$$S_{p}^{*} = \frac{\Lambda_{p}}{\mu_{h} + \lambda_{h}^{*}},\mspace{6mu}\mspace{6mu}\mspace{6mu} I_{h}^{*} = \frac{\Lambda_{p}\lambda_{h}^{*}}{\left( \mu_{h} + \kappa_{h} \right)\left( \mu_{h} + \lambda_{h}^{*} \right)}$$with the force of infection$$\lambda_{h}^{*} = \frac{\beta_{h}I_{h}^{*}}{\left( S_{p}^{*} + I_{h}^{*} \right)}.$$Simple transformation of [(6)](#eq0006){ref-type="disp-formula"} and [(7)](#eq0007){ref-type="disp-formula"} leads to following polynomial in $\lambda_{h}^{*}:$ $$\lambda_{h}^{*}\left( \lambda_{h}^{*} + \left( 1 - \mathcal{R}_{h} \right)\left( \mu_{h} + \kappa_{h} \right) \right) = 0.$$Hence we have $\lambda_{h}^{*} = - \left( 1 - \mathcal{R}_{h} \right)\left( \mu_{h} + \kappa_{h} \right)$ which has a biological meaning only if the force of infection $\lambda_{h}^{*}$ is non negative, meaning that $\left. \left( 1 - \mathcal{R}_{h} \right)\left( \mu_{h} + \kappa_{h} \right) < 0\mspace{6mu}\mspace{6mu}\Longleftrightarrow\mspace{6mu}\mspace{6mu}\mathcal{R}_{h} > 1. \right.$ Furthermore, in terms of $\mathcal{R}_{h},$ [(6)](#eq0006){ref-type="disp-formula"} gives$$S_{p}^{*} = \frac{\Lambda_{p}}{\kappa_{h}\left( \mathcal{R}_{h} - 1 \right) + \mu_{h}\mathcal{R}_{h}},\mspace{6mu}\mspace{6mu}\mspace{6mu} I_{h}^{*} = \frac{\left( \mathcal{R}_{h} - 1 \right)\Lambda_{p}}{\kappa_{h}\left( \mathcal{R}_{h} - 1 \right) + \mu_{h}\mathcal{R}_{h}}.$$We have then shown the resultsLemma 4.4*The model* [(2)](#eq0002){ref-type="disp-formula"} *of HIV has a unique endemic equilibrium if and only if* $\mathcal{R}_{h} > 1.$ *Moreover, that unique endemic equilibrium locally asymptotically stable if* $\mathcal{R}_{h} > 1.$

5. Sub-model: COVID-19 only {#sec0009}
===========================

We establish the COVID-19 only sub-model from model [(1)](#eq0001){ref-type="disp-formula"} by putting $I_{h} = 0,\mspace{6mu} I_{hc} = 0$ which yields$$\left\{ \begin{array}{l}
{\frac{S_{p}}{dt} = \Lambda_{p} + \gamma I_{c} - \left( \lambda_{c} + \mu_{h} \right)S_{p},} \\
{\frac{I_{c}}{dt} = \lambda_{c}S_{p} - \left( \mu_{h} + \kappa_{c} + \gamma \right)I_{c},} \\
{\frac{S_{r}}{dt} = \Lambda_{r} - \left( \mu_{c} + \lambda_{r} \right)S_{r}} \\
{\frac{I_{r}}{dt} = \lambda_{r}S_{r} - \mu_{c}I_{r},} \\
\end{array} \right.$$with the force of infection *λ~c~* and *λ~r~* reading respectively as$$\lambda_{c} = \frac{\beta_{c}\sigma I_{r}}{N_{p}},$$and$$\lambda_{r} = \frac{\beta_{r}\sigma I_{r}}{N_{r}},$$

5.1. Basic reproduction number {#sec0010}
------------------------------

The disease-free equilibrium (or the DFE) of the COVID-19 only system [(10)](#eq0010){ref-type="disp-formula"} reads as$$E^{0} = \left( \frac{\Lambda_{p}}{\mu_{h}},0,\frac{\Lambda_{r}}{\mu_{c}},0 \right)$$Exploiting the next generation operator $FV^{- 1}$ as detailed in [@bib0017] leads to the COVID-19 only system [(10)](#eq0010){ref-type="disp-formula"} written into the matrix form $\overset{˙}{X} = \mathcal{F}\left( X \right) - \mathcal{V}\left( X \right)$ where the matrices $\mathcal{F}$ and $\mathcal{V}$ are respectively given by$$\mathcal{F}\left( X \right) = \begin{pmatrix}
\frac{\beta_{c}\sigma I_{r}\left( t \right)S_{p}\left( t \right)}{I_{c}\left( t \right) + S_{p}\left( t \right)} \\
\frac{\beta_{r}\sigma I_{r}\left( t \right)S_{r}\left( t \right)}{I_{r}\left( t \right) + S_{r}\left( t \right)} \\
0 \\
0 \\
\end{pmatrix}$$and$$\mathcal{V}\left( X \right) = \begin{pmatrix}
{- \left( \mu_{h} + \kappa_{c} + \gamma \right)I_{c}\left( t \right)} \\
{- \mu_{c}I_{r}} \\
{\Lambda_{p} + \gamma I_{c} - \left( {\mu_{h} + \frac{\beta_{c}\sigma I_{r}\left( t \right)}{I_{c}\left( t \right) + S_{p}\left( t \right)}} \right)S_{p}\left( t \right)} \\
{\Lambda_{r} - \left( {\mu_{c} + \frac{\beta_{r}\sigma I_{r}\left( t \right)}{I_{r}\left( t \right) + S_{r}\left( t \right)}} \right)S_{r}\left( t \right)} \\
\end{pmatrix}$$Evaluated at the DFE *E* ^0^, the Jacobian of those matrices yields$$F = \left\lbrack \frac{\partial\mathcal{F}_{i}}{\partial x_{j}}\left( E^{0} \right) \right\rbrack = \begin{pmatrix}
0 & {\beta_{c}\sigma} \\
0 & {\beta_{r}\sigma\frac{\Lambda_{p}^{2}\mu_{c}^{2}}{\mu_{h}^{2}\Lambda_{r}^{2}}} \\
\end{pmatrix}$$and$$V = \left\lbrack \frac{\partial\mathcal{V}_{i}}{\partial x_{j}}\left( E^{0} \right) \right\rbrack = \begin{pmatrix}
{\mu_{h} + \kappa_{c} + \gamma} & 0 \\
0 & \mu_{c} \\
\end{pmatrix}.$$Hence the basic reproduction number $\mathcal{R}_{c}$ is the spectral radius$$\mathcal{R}_{c} = \rho\left( FV^{- 1} \right) = \beta_{r}\sigma\left( \frac{\Lambda_{p}}{\mu_{h}} \right)^{2}\frac{\mu_{c}}{\Lambda_{r}^{2}}.$$

Following the same approach as in [Proposition 4.2](#enun0002){ref-type="statement"}, we easily show thatProposition 5.1*The DFE* $E^{0} = \left( \frac{\Lambda_{p}}{\mu_{h}},0,\frac{\Lambda_{r}}{\mu_{c}},0 \right)$ *of the COVID-19 only sub-model* [(10)](#eq0010){ref-type="disp-formula"} *is locally-asymptotically stable if* $\mathcal{R}_{c} < 1,$ *and unstable if* $\mathcal{R}_{c} > 1.$

6. Possibility of backward bifurcation for the COVID-19 sub-model {#sec0011}
=================================================================

Our aim here in this section is to look at the conditions under which there exists a backward bifurcation for the model [(10)](#eq0010){ref-type="disp-formula"}. Recall that this type of bifurcation happens when a stable DFE and a stable endemic equilibrium exist together for some values of the basic reproduction number $\mathcal{R}_{c}$ less than one. Hence, we have to find conditions for which endemic equilibrium $E^{*} = \left( S_{p}^{*},I_{c}^{*},S_{r}^{*},I_{r}^{*} \right).$ We pose$$\left\{ \begin{array}{l}
{0 = \Lambda_{p} + \gamma I_{c} - \left( \lambda_{c} + \mu_{h} \right)S_{p},} \\
{0 = \lambda_{c}S_{p} - \left( \mu_{h} + \kappa_{c} + \gamma \right)I_{c},} \\
{0 = \Lambda_{r} - \left( \mu_{c} + \lambda_{r} \right)S_{r}} \\
{0 = \lambda_{r}S_{r} - \mu_{c}I_{r},} \\
\end{array} \right.$$which yields$$S_{p}^{*} = \frac{\Lambda_{p}\left( \mu_{h} + \kappa_{c} + \gamma \right)}{\lambda_{c}^{*}\left( \mu_{h} + \kappa_{c} \right) + \mu_{h}\left( \mu_{h} + \kappa_{c} + \gamma \right)}$$ $$I_{c}^{*} = \frac{\Lambda_{p}\lambda_{c}^{*}}{\lambda_{c}^{*}\left( \mu_{h} + \kappa_{c} \right) + \mu_{h}\left( \mu_{h} + \kappa_{c} + \gamma \right)}$$ $$S_{r}^{*} = \frac{\Lambda_{r}}{\lambda_{r}^{*} + \mu_{c}}$$ $$I_{r}^{*} = \frac{\Lambda_{r}\lambda_{r}^{*}}{\mu_{c}\left( \lambda_{r}^{*} + \mu_{c} \right)}$$with the forces of infection$$\lambda_{c}^{*} = \frac{\beta_{c}\sigma I_{r}^{*}}{\left( S_{p}^{*} + I_{c}^{*} \right)},\mspace{6mu}\mspace{6mu}\mspace{6mu}\lambda_{r}^{*} = \frac{\beta_{r}\sigma I_{r}^{*}}{\left( S_{r}^{*} + I_{r}^{*} \right)}$$Simple transformation of [(11)](#eq0011){ref-type="disp-formula"} and [(12)](#eq0012){ref-type="disp-formula"} leads to following polynomial in $\lambda_{c}^{*}:$ $$\lambda_{c}^{*}\left( Q_{1}\left( \lambda_{c}^{*} \right)^{2} + Q_{2}\lambda_{c}^{*} + Q_{3} \right) = 0.$$where$$Q_{1} = \Lambda_{p}\mu_{c}\left( \mu_{c} + \beta_{r}\sigma \right),$$ $$Q_{2} = \left( T - \mathcal{R}_{c} \right)\frac{\Lambda_{p}\mu_{c}^{2}\left( \mu_{h} + \kappa_{c} + \gamma \right)\left( \mu_{h} + \kappa_{c} \right)}{\mu_{h}},$$ $$Q_{3} = \left( 1 - \mathcal{R}_{c} \right)\Lambda_{p}\mu_{c}^{2}\left( \mu_{h} + \kappa_{c} + \gamma \right)^{2}$$

and$$T = \frac{\left( 2\mu_{c} + \beta_{r}\sigma \right)\mu_{h}}{\mu_{c}\left( \mu_{h} + \kappa_{c} \right)}$$We have here many endemic equilibrium points (solutions $\lambda_{c}^{*}$) to$$Q_{1}\left( \lambda_{c}^{*} \right)^{2} + Q_{2}\lambda_{c}^{*} + Q_{3}$$and the solution ($\lambda_{c}^{*} = 0$) that is related to the DEF. Let$$\widetilde{\sigma} = \frac{\left( \kappa_{c} - \mu_{h} \right)\mu_{c}}{\beta_{r}\mu_{h}}$$then clearly$$\left. T > 1\Longleftrightarrow\sigma > \widetilde{\sigma}. \right.$$We have the following resultsProposition 6.1*The necessary condition for the existence of backward (subcritical) bifurcation for the model* [(10)](#eq0010){ref-type="disp-formula"} *is* $\sigma < \widetilde{\sigma}.$ *Furthermore, there is* $0 < {\widetilde{\mathcal{R}}}_{c} < 1$ *so that:- Model* [(10)](#eq0010){ref-type="disp-formula"} *has one and only one endemic equilibrium point if* ${\widetilde{\mathcal{R}}}_{c} = \mathcal{R}_{c}.$*- Model* [(10)](#eq0010){ref-type="disp-formula"} *has two endemic equilibrium points if* $\mathcal{R}_{c} \in \left( {\widetilde{\mathcal{R}}}_{c},\mspace{6mu} 1 \right).$*- Model* [(10)](#eq0010){ref-type="disp-formula"} *has one endemic equilibrium point if* $\mathcal{R}_{c} \geq 1.$*- Model* [(10)](#eq0010){ref-type="disp-formula"} *has no endemic equilibrium point if* $\mathcal{R}_{c} < {\widetilde{\mathcal{R}}}_{c}.$*The necessary condition for the existence of transcritical bifurcation for the model* [(10)](#eq0010){ref-type="disp-formula"} *is* $\sigma \geq \widetilde{\sigma}.$ ProofTo prove this, we use the equivalence relation [(13)](#eq0013){ref-type="disp-formula"}-[(15)](#eq0015){ref-type="disp-formula"} where it is obvious to see that *Q* ~1~ \> 0. Moreover, *Q* ~2~ \> 0 if $T > \mathcal{R}_{c}$ and *Q* ~2~ \< 0 if $T < \mathcal{R}_{c}.$ Also *Q* ~3~ \> 0 if $\mathcal{R}_{c} < 1$ and *Q* ~3~ \< 0 if $\mathcal{R}_{c} > 1.$From [(15)](#eq0015){ref-type="disp-formula"} we have *T* \< 1 when $\sigma < \widetilde{\sigma}.$ Hence, when $\mathcal{R}_{c} \geq 1,$ we have *Q* ~2~ ≤ 0 meaning $\mathcal{R}_{c} \geq 1 > T$ and *Q* ~3~ ≤ 0, and [Eq. (14)](#eq0014){ref-type="disp-formula"} has one and only one positive root. However, [Eq. (14)](#eq0014){ref-type="disp-formula"} has no positive root when $\mathcal{R}_{c} \leq T < 1$ meaning *Q* ~2~ ≥ 0 and *Q* ~3~ \> 0.Now in the case where $1 \geq \mathcal{R}_{c} > T$ we also have *Q* ~2~ \< 0 and *Q* ~3~ ≥ 0. If $\Delta: = F\left( \mathcal{R}_{c} \right) = Q_{2}^{2} - 4Q_{1}Q_{3}$ denotes the discriminant of [(14)](#eq0014){ref-type="disp-formula"} and a functional of $\mathcal{R}_{c}$ then$$\begin{array}{ccl}
{F^{\prime}\left( \mathcal{R}_{c} \right)} & = & {- 2\left( T - \mathcal{R}_{c} \right)^{2}\frac{\Lambda_{p}\mu_{c}^{2}\left( \mu_{h} + \kappa_{c} + \gamma \right)\left( \mu_{h} + \kappa_{c} \right)}{\mu_{h}}} \\
 & & {+ \, 4Q_{1}\Lambda_{p}\mu_{c}^{2}\left( \mu_{h} + \kappa_{c} + \gamma \right)^{2} > 0} \\
\end{array}$$for $\mathcal{R}_{c} \in \left( T,1 \right).$ *F* is strictly increasing in (*T*, 1) and $F\left( T \right) = - 4Q_{1}Q_{3} < 0$ and $F\left( 1 \right) = Q_{2}^{2} > 0.$ Therefore, there is ${\widetilde{\mathcal{R}}}_{c} \in \left( T,1 \right)$ so that $F\left( {\widetilde{\mathcal{R}}}_{c} \right) = 0$ with *F* \< 0 in $\left( T,{\widetilde{\mathcal{R}}}_{c} \right)$ and *F* \> 0 in $\left( {\widetilde{\mathcal{R}}}_{c},1 \right).$ Hence, - when $\mathcal{R}_{c} \in \left( {\widetilde{\mathcal{R}}}_{c},\mspace{6mu} 1 \right).,$ [Eq. (14)](#eq0014){ref-type="disp-formula"} has two real and positive roots (since *Q* ~2~ \< 0 and *Q* ~3~ \> 0). That leads to model [(10)](#eq0010){ref-type="disp-formula"} having also two endemic equilibrium points. Similarly, - [Eq. (14)](#eq0014){ref-type="disp-formula"} has one positive root when $\mathcal{R}_{c} = {\widetilde{\mathcal{R}}}_{c},$ - [Eq. (14)](#eq0014){ref-type="disp-formula"} has no positive root when if $T < \mathcal{R}_{c} < {\widetilde{\mathcal{R}}}_{c},$ which concludes the proof. □

Now that we have a conditions on existence of a subcritical bifurcation for the COVID-19 model let us have a look at the full model. Note that according to the definition of the *σ* and *β~c~* it is clear that $\delta = \sigma\beta_{c}$ represents the COVID-19 transmission rate per vector-to-host contact per unit time.

7. The full HIV and COVID-19 combined model [(1)](#eq0001){ref-type="disp-formula"} {#sec0012}
===================================================================================

7.1. Stability of the DFE {#sec0013}
-------------------------

Rewrite the model [(1)](#eq0001){ref-type="disp-formula"} as$$\left\{ \begin{array}{l}
{\frac{S_{p}}{dt} = \Lambda_{p} + \gamma I_{c} - \left( {\frac{\beta_{c}\sigma I_{r}}{N_{p}} + \frac{\beta_{h}\left( I_{h} + \xi_{hc}I_{hc} \right)}{N_{p}} + \mu_{h}} \right)S_{p},} \\
{\frac{I_{c}}{dt} = \frac{\beta_{c}\sigma I_{r}}{N_{p}}S_{p} - \left( {\varepsilon\frac{\beta_{h}\left( I_{h} + \xi_{hc}I_{hc} \right)}{N_{p}} + \mu_{h} + \kappa_{c} + \gamma} \right)I_{c},} \\
{\frac{I_{h}}{dt} = \frac{\beta_{h}\left( I_{h} + \xi_{hc}I_{hc} \right)}{N_{p}}S_{p} + \varpi I_{hc} - \left( \theta\left( \frac{\beta_{c}\sigma I_{r}}{N_{p}} \right) + \mu_{h} + \kappa_{h} \right)I_{h},} \\
{\frac{I_{hc}}{dt} = \varepsilon\frac{\beta_{h}\left( I_{h} + \xi_{hc}I_{hc} \right)}{N_{p}}I_{c} + \theta\left( \frac{\beta_{c}\sigma I_{r}}{N_{p}} \right)I_{h} - \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)I_{hc},} \\
{\frac{S_{r}}{dt} = \Lambda_{r} - \left( {\mu_{c} + \frac{\beta_{r}\sigma I_{r}}{N_{r}}} \right)S_{r}} \\
{\frac{I_{r}}{dt} = \frac{\beta_{r}\sigma I_{r}}{N_{r}}S_{r} - \mu_{c}I_{r}.} \\
\end{array} \right.$$We can state the following resultProposition 7.1*The DFE E* ^0^ *of the combined HIV and COVID-19 model* [(1)](#eq0001){ref-type="disp-formula"} *is locally-asymptotically stable if* $\max\left\{ \mathcal{R}_{h},\mathcal{R}_{c} \right\} < 1,$ *and unstable if* $\max\left\{ \mathcal{R}_{h},\mathcal{R}_{c} \right\} > 1.$ ProofLet $\mathcal{R}_{0} = \max\left\{ \mathcal{R}_{h},\mathcal{R}_{c} \right\}$ and let $E^{0} = \left( S_{p}^{0},I_{c}^{0},I_{h}^{0},I_{hc}^{0},S_{r}^{0},I_{r}^{0} \right)$ denotes the disease-free equilibrium point. We can investigate the stability of the DFE *E* ^0^ by analyzing the eigenvalues of the Jacobian matrix $\left. \mathbb{J} \right|_{E^{0}}$ evaluated at *E* ^0^. Linearizing the model [(16)](#eq0016){ref-type="disp-formula"} at the DFE *E* ^0^ yields$$\left\{ \begin{array}{l}
{\frac{y_{1}}{dt} = - \mu_{h}y_{1} + \gamma y_{2} - \beta_{h}y_{3} - \beta_{h}\xi_{hc}y_{4} - \beta_{c}\sigma y_{6},} \\
{\frac{y_{2}}{dt} = - \left( \mu_{h} + \kappa_{c} + \gamma \right)y_{2} + \beta_{c}\sigma y_{6},} \\
{\frac{y_{3}}{dt} = \left( \beta_{h} - \mu_{h} - \kappa_{c} \right)y_{3} + \left( \beta_{h}\xi_{hc} + \varpi \right)y_{4},} \\
{\frac{y_{4}}{dt} = - \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)y_{4},} \\
{\frac{y_{5}}{dt} = - \frac{\Lambda_{r}\beta_{r}\sigma\mu_{h}}{\Lambda_{p}\mu_{c}}y_{2} - \mu_{c}y_{5},} \\
{\frac{y_{6}}{dt} = \frac{\Lambda_{r}\beta_{r}\sigma\mu_{h}}{\Lambda_{p}\mu_{c}}y_{2} - \mu_{c}y_{6},} \\
\end{array} \right.$$where we have set$$y_{1}\left( t \right) = S_{p}\left( t \right) - S_{p}^{0},\mspace{6mu}\mspace{6mu} y_{2}\left( t \right) = I_{c}\left( t \right) - I_{c}^{0},\mspace{6mu}\mspace{6mu} y_{3}\left( t \right) = I_{h}\left( t \right) - I_{h}^{0}$$ $$y_{4}\left( t \right) = I_{hc}\left( t \right) - I_{hc}^{0},\mspace{6mu}\mspace{6mu} y_{5}\left( t \right) = S_{r}\left( t \right) - S_{r}^{0},\mspace{6mu}\mspace{6mu} y_{6}\left( t \right) = I_{r}\left( t \right) - I_{r}^{0}.$$Assuming that solutions to [(17)](#eq0017){ref-type="disp-formula"} can take the exponential from$$y_{1}\left( t \right) = c_{1}\text{e}^{\lambda t},\mspace{6mu}\mspace{6mu} y_{2}\left( t \right) = c_{2}\text{e}^{\lambda t},\mspace{6mu}\mspace{6mu} y_{3}\left( t \right) = c_{3}\text{e}^{\lambda t}$$ $$y_{4}\left( t \right) = c_{4}\text{e}^{\lambda t},\mspace{6mu}\mspace{6mu} y_{5}\left( t \right) = c_{5}\text{e}^{\lambda t},\mspace{6mu}\mspace{6mu} y_{6}\left( t \right) = c_{6}\text{e}^{\lambda t},$$the substitution into [(17)](#eq0017){ref-type="disp-formula"} and canceling the term e^*λt*^ yields$$\left\{ \begin{array}{l}
{0 = \left( \lambda + \mu_{h} \right)c_{1} - \gamma c_{2} + \beta_{h}c_{3} + \beta_{h}\xi_{hc}c_{4} + \beta_{c}\sigma c_{6},} \\
{0 = \left( \lambda + \mu_{h} + \kappa_{c} + \gamma \right)c_{2} - \beta_{c}\sigma c_{6},} \\
{0 = \left( \lambda - \beta_{h} + \mu_{h} + \kappa_{c} \right)c_{3} - \left( \beta_{h}\xi_{hc} + \varpi \right)c_{4},} \\
{0 = \left( \lambda + \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)c_{4},} \\
{0 = \frac{\Lambda_{r}\beta_{r}\sigma\mu_{h}}{\Lambda_{p}\mu_{c}}c_{2} + \left( \lambda + \mu_{c} \right)c_{5},} \\
{0 = - \frac{\Lambda_{r}\beta_{r}\sigma\mu_{h}}{\Lambda_{p}\mu_{c}}c_{2} + \left( \lambda + \mu_{c} \right)c_{6}.} \\
\end{array} \right.$$This system has a characteristic equation given by$$\left| \begin{matrix}
{\mu_{h} + \lambda} & {- \gamma} & \beta_{h} & {\beta_{h}\xi_{hc}} & 0 & {\beta_{c}\sigma} \\
0 & {\left( \mu_{h} + \kappa_{c} + \gamma \right) + \lambda} & 0 & 0 & 0 & {- \beta_{c}\sigma} \\
0 & 0 & {\left( \mu_{h} + \kappa_{h} - \beta_{h} \right) + \lambda} & {- \beta_{h}\xi_{hc} - \varpi} & 0 & 0 \\
0 & 0 & 0 & {\left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right) + \lambda} & 0 & 0 \\
0 & \frac{\beta_{r}\sigma\mu_{h}\Lambda_{r}}{\Lambda_{p}\mu_{c}} & 0 & 0 & 0 & 0 \\
0 & {- \frac{\beta_{r}\sigma\mu_{h}\Lambda_{r}}{\Lambda_{p}\mu_{c}}} & 0 & 0 & 0 & {\mu_{c} + \lambda} \\
\end{matrix} \right| = 0,$$equivalently$$Z_{1}\left( \mathcal{R}_{h} \right)Z_{2}\left( \mathcal{R}_{c} \right)\left( \mu_{h} + \lambda \right)\left( \mu_{c} + \lambda \right)\left( \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right) + \lambda \right) = 0$$with$$Z_{1}\left( \mathcal{R}_{h} \right) = \left( 1 - \mathcal{R}_{h} \right)\left( \mu_{h} + \kappa_{h} \right) + \lambda$$ $$Z_{2}\left( \mathcal{R}_{c} \right) = \left( 1 - \mathcal{R}_{c} \right)\left( \mu_{h} + \kappa_{c} + \gamma \right)\mu_{c} + \lambda\left( \mu_{h} + \kappa_{c} + \gamma + \mu_{c} \right) + \lambda^{2}$$Hence, from [(18)](#eq0018){ref-type="disp-formula"} some of the eigenvalues $\left. \mathbb{J} \right|_{E^{0}}$ are given by$$\lambda_{1} = - \mu_{h},\mspace{6mu}\lambda_{2} = - \mu_{c},\mspace{6mu}\lambda_{3} = - \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)$$which are all negative. The fourth eigenvalue is the root of $Z_{1}\left( \mathcal{R}_{h} \right) = 0$ and reads as $\lambda_{4} = - \left( 1 - \mathcal{R}_{h} \right)\left( \mu_{h} + \kappa_{h} \right).$ Obviously, *λ* ~4~ \< 0 when $\mathcal{R}_{h} < 1$ and *λ* ~4~ \> 0 when $\mathcal{R}_{h} > 1.$ From the previous section where the DEF of the COVID-19 only model was analyzed, $Z_{2}\left( \mathcal{R}_{c} \right) = 0$ refers to the corresponding characteristic equations. Hence, we showed ([Proposition 5.1](#enun0005){ref-type="statement"}) that $Z_{2}\left( \mathcal{R}_{c} \right) = 0$ has roots all with negative real parts for $\mathcal{R}_{c} < 1.$ Moreover, $Z_{2}\left( \mathcal{R}_{c} \right) = 0$ has at least a root with a positive real part when $\mathcal{R}_{c} > 1.$ Finally, for $\mathcal{R}_{0} = \max\left\{ \mathcal{R}_{h},\mathcal{R}_{c} \right\} < 1$ [Eq. (20)](#eq0020){ref-type="disp-formula"} has roots all with negative real parts and has at least a root with a positive real part when $\mathcal{R}_{0} > 1.$  □

The bifurcation analysis are depicted in [Figs. 11](#fig0011){ref-type="fig"} and [12](#fig0012){ref-type="fig"} showing condition for the model to have forward and backward bifurcations respectively. and show that the model contains a backward bifurcation under certain conditions. We also study different scenarios of stability and unstability state of equilibrium points (the DFE $E_{0} = \left( 762224.14,0,70711.11,0 \right)$ and the endemic equilibrium point) as shown in [Fig. 13](#fig0013){ref-type="fig"}, [Fig. 14](#fig0014){ref-type="fig"}, [Fig. 15](#fig0015){ref-type="fig"} . The globally stable DFE *E* ~0~ is illustrated in [Fig. 13](#fig0013){ref-type="fig"} while a stable endemic equilibrium, namely $E_{2} = \left( 1938.62,657.11,34941.36,36511.93 \right),$ and an unstable endemic equilibrium $E_{1} = \left( 13687.91,412.38,61442.11,8992.32 \right)$ are shown in [Fig. 12](#fig0012){ref-type="fig"} when $\beta_{r} = 0.07,\mspace{6mu}\sigma = 0.155\mspace{6mu}\left( \mathcal{R}_{c} = 0.50167 \right)$. [Fig. 15](#fig0015){ref-type="fig"} shows that there exists a globally stable endemic equilibrium $E^{*} = \left( 96211.13,413.18,68644.21,6513.13 \right)$ for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"} and an unstable DFE *E* ~0~, when $\beta_{r} = 1.60,\mspace{6mu}\sigma = 6.33 \times 10^{- 13}\mspace{6mu}\left( \mathcal{R}_{c} = 1.07121 \right).$ Fig. 11Illustration of the forward bifurcation process from *I~h~* versus $\delta = \sigma\beta_{c}$ for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"} with $\beta_{r} = 0.03$ and also with $\Lambda_{p} = 1000,\Lambda_{r} = 2500,\mu_{h} = 0.0131,\mu_{c} = 0.035$ and $\kappa_{c} = 199 \times 10^{- 4}.$Fig. 11Fig. 12Illustration of the backward bifurcation process from *I~h~* versus $\delta = \sigma\beta_{c}$ for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"} with $\beta_{r} = 0.05,$ and also with $\Lambda_{p} = 1000,\Lambda_{r} = 2500,\mu_{h} = 0.0131,\mu_{c} = 0.035$ and $\kappa_{c} = 199 \times 10^{- 4}.$Fig. 12Fig. 13Existence of a globally stable disease-free equilibrium $E_{0} = \left( 762224.14,0,70711.11,0 \right)$ for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"} when $\beta_{r} = 0.05,\mspace{6mu}\sigma = 0.217\mspace{6mu}\left( \mathcal{R}_{c} = 0.33379 \right).$Fig. 13Fig. 14Existence for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"}, of two stable equilibrium points: The DFE *E*~0~, a stable endemic equilibrium $E_{2} = \left( 1938.62,657.11,34941.36,36511.93 \right),$ and an unstable endemic equilibrium $E_{1} = \left( 13687.91,412.38,61442.11,8992.32 \right)$ when $\beta_{r} = 0.07,\mspace{6mu}\sigma = 0.155\mspace{6mu}\left( \mathcal{R}_{c} = 0.50167 \right).$Fig. 14Fig. 15Existence of a globally stable endemic equilibrium $E^{*} = \left( 96211.13,413.18,68644.21,6513.13 \right)$ for the COVID-19 system [(10)](#eq0010){ref-type="disp-formula"} and an unstable DFE *E*~0~, when $\beta_{r} = 1.60,\mspace{6mu}\sigma = 6.33 \times 10^{- 13}\mspace{6mu}\left( \mathcal{R}_{c} = 1.07121 \right).$Fig. 15

8. Endemic equilibria's existence for combined HIV and COVID-19 model [(1)](#eq0001){ref-type="disp-formula"} {#sec0014}
=============================================================================================================

The endemic equilibrium, denoted by $E^{*} = \left( S_{p}^{*},I_{c}^{*},I_{h}^{*},I_{hc}^{*},S_{r}^{*},I_{r}^{*} \right)$ is obtained by solving$$\left\{ \begin{array}{l}
{0 = \Lambda_{p} + \gamma I_{c}^{*} - \left( \lambda_{c}^{*} + \lambda_{h}^{*} + \mu_{h} \right)S_{p}^{*},} \\
{0 = \lambda_{c}^{*}S_{p}^{*} - \left( \varepsilon\lambda_{h}^{*} + \mu_{h} + \kappa_{c} + \gamma \right)I_{c}^{*},} \\
{0 = \lambda_{h}^{*}S_{p}^{*} + \varpi I_{hc}^{*} - \left( \theta\lambda_{c}^{*} + \mu_{h} + \kappa_{h} \right)I_{h}^{*},} \\
{0 = \varepsilon\lambda_{h}^{*}I_{c}^{*} + \theta\lambda_{c}^{*}I_{h}^{*} - \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)I_{hc}^{*},} \\
{0 = \Lambda_{r} - \left( \mu_{c} + \lambda_{r}^{*} \right)S_{r}^{*}} \\
{0 = \lambda_{r}^{*}S_{r}^{*} - \mu_{c}I_{r}^{*},} \\
\end{array} \right.$$

where $\lambda_{c}^{*},\mspace{6mu}\lambda_{h}^{*}$ and $\lambda_{r}^{*}$ are respectively the forces of infection a steady-state reading as$$\lambda_{c}^{*} = \frac{\beta_{c}\sigma I_{r}^{*}}{N_{p}^{*}},\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} N_{p}^{*} = S_{p}^{*} + I_{c}^{*} + I_{h}^{*} + I_{hc}^{*}$$ $$\lambda_{h}^{*} = \frac{\beta_{h}\left( I_{h}^{*} + \xi_{hc}I_{hc}^{*} \right)}{N_{p}^{*}},$$ $$\lambda_{r}^{*} = \frac{\beta_{r}\sigma I_{r}^{*}}{N_{r}^{*}},\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} N_{r}^{*} = S_{r}^{*} + I_{r}^{*}.$$Hence after solving [(21)](#eq0021){ref-type="disp-formula"}, we obtain$$S_{p}^{*} = \frac{\Lambda_{p}\left( \mu_{h} + \kappa_{c} + \gamma + \varepsilon\lambda_{h}^{*} \right)}{\lambda_{c}^{*}\left( \mu_{h} + \kappa_{c} + \varepsilon\lambda_{h}^{*} \right) + \left( \lambda_{c}^{*} + \mu_{h} \right)\left( \mu_{h} + \kappa_{c} + \gamma + \varepsilon\lambda_{h}^{*} \right)}$$ $$I_{c}^{*} = \frac{\Lambda_{p}\lambda_{c}^{*}}{\lambda_{c}^{*}\left( \mu_{h} + \kappa_{c} + \varepsilon\lambda_{h}^{*} \right) + \left( \lambda_{c}^{*} + \mu_{h} \right)\left( \mu_{h} + \kappa_{c} + \gamma + \varepsilon\lambda_{h}^{*} \right)}$$ $$I_{h}^{*} = \frac{\Lambda_{p}\lambda_{h}^{*}\left( \left( \mu_{h} + \tau\kappa_{c} + \nu\kappa_{h} + \varpi \right)\left( \mu_{h} + \kappa_{c} + \gamma + \varepsilon\lambda_{h}^{*} \right) + \varpi\varepsilon\lambda_{c}^{*} \right)}{A_{1}\left( \gamma\left( \lambda_{h}^{*} + \mu_{h} \right) + \left( \mu_{h} + \kappa_{c} + \varepsilon\lambda_{h}^{*} \right)\left( \lambda_{h}^{*} + \lambda_{c}^{*} + \mu_{h} \right) \right)}$$ $$I_{hc}^{*} = \frac{\Lambda_{p}\lambda_{h}^{*}\lambda_{c}^{*}\left( \varepsilon\left( \mu_{h} + \kappa_{c} + \varepsilon\lambda_{h}^{*} \right) + \theta\left( \mu_{h} + \kappa_{c} + \gamma + \varepsilon\lambda_{h}^{*} \right) \right)}{A_{1}\left( \gamma\left( \lambda_{h}^{*} + \mu_{h} \right) + \left( \mu_{h} + \kappa_{c} + \varepsilon\lambda_{h}^{*} \right)\left( \lambda_{h}^{*} + \lambda_{c}^{*} + \mu_{h} \right) \right)}$$ $$S_{r}^{*} = \frac{\Lambda_{r}}{\lambda_{r}^{*} + \mu_{c}}$$ $$I_{r}^{*} = \frac{\Lambda_{r}\lambda_{r}^{*}}{\mu_{c}\left( \lambda_{r}^{*} + \mu_{c} \right)}$$with$$A_{1} = \varpi\left( \mu_{h} + \kappa_{h} \right) + \left( \kappa_{h} + \theta\lambda_{c}^{*} + \mu_{h} \right)\left( \tau\kappa_{c} + \mu_{h} + \nu\kappa_{h} \right).$$After some transformations using the later system and the forces of infection [(22)](#eq0022){ref-type="disp-formula"}, we obtain characteristic equations with the following roots: $\lambda_{h}^{*} = 0,\mspace{6mu}\mspace{6mu}\mspace{6mu}\lambda_{c}^{*} = 0$ plus the roots of$$K_{1}\left( \lambda_{h}^{*},\lambda_{c}^{*} \right) = 0$$and$$K_{2}\left( \lambda_{h}^{*},\lambda_{c}^{*} \right) = 0$$where *K* ~1~ and *K* ~2~ are respectively complex polynomials of order two in $\lambda_{c}^{*}$ and order four in $\lambda_{h}^{*}$ with coefficients which are also complex polynomials of order two in $\lambda_{h}^{*}$ and order four in $\lambda_{c}^{*}$ respectively.

Hence the later results show that there are some values for both reproduction numbers $\mathcal{R}_{c}$ and $\mathcal{R}_{h}$ and therefore $\mathcal{R}_{0}$ for which the only obvious equilibrium point is the DFE. Similarly there some values for both reproduction numbers $\mathcal{R}_{c}$ and $\mathcal{R}_{h}$ and therefore $\mathcal{R}_{0}$ for which the full combined HIV and COVID-19 model [(16)](#eq0016){ref-type="disp-formula"} has either a HIV equilibrium point or a COVID-19 equilibrium point. Lastly, there some values for both reproduction numbers $\mathcal{R}_{c}$ and $\mathcal{R}_{h}$ and therefore $\mathcal{R}_{0}$ for which the combined HIV and COVID-19 model [(16)](#eq0016){ref-type="disp-formula"} a has a co-infection equilibrium point. Let us now study the COVID-19 global picture by numerically investigate the generalized version of the model [(16)](#eq0016){ref-type="disp-formula"}.

9. Generalised COVID-19 model {#sec0015}
=============================

we generalize the COVID-19 model [(10)](#eq0010){ref-type="disp-formula"} as$$\left\{ \begin{array}{l}
{{}^{C}D_{t}^{\alpha}\left( S_{p}\left( t \right) \right) = \Lambda_{p} + \gamma I_{c} - \left( \lambda_{c} + \mu_{h} \right)S_{p},} \\
{{}^{C}D_{t}^{\alpha}\left( I_{c}\left( t \right) \right) = \lambda_{c}S_{p} - \left( \mu_{h} + \kappa_{c} + \gamma \right)I_{c},} \\
{{}^{C}D_{t}^{\alpha}\left( S_{r}\left( t \right) \right) = \Lambda_{r} - \left( \mu_{c} + \lambda_{r} \right)S_{r}} \\
{{}^{C}D_{t}^{\alpha}\left( I_{r}\left( t \right) \right) = \lambda_{r}S_{r} - \mu_{c}I_{r},} \\
\end{array} \right.$$with the force of infection *λ~c~* and *λ~r~* reading respectively as$$\lambda_{c} = \frac{\beta_{c}\sigma I_{r}}{N_{p}},$$and$$\lambda_{r} = \frac{\beta_{r}\sigma I_{r}}{N_{r}},$$and where ${}^{C}D_{t}^{\alpha}$ is the classical Caputo fractional derivative that, for the order *α*, and for any *t* \> 0, is defined as$${}^{C}D_{t}^{\alpha}S\left( t \right) = I^{1 - \alpha}\frac{d}{dt}S\left( t \right),\quad\, 0 < \alpha \leq 1,$$where $- \infty \leq a < t,\,\, b > a$ and $\left. S:\left( a,b \right)\longrightarrow\mathbb{R} \right.$ is a real and locally integrable function and$$I^{\alpha}S\left( t \right) = \frac{1}{\Gamma\left( \alpha \right)}\int_{a}^{t}\frac{S\left( \tau \right)}{\left( t - \tau \right)^{1 - \alpha}}d\tau,$$is the fractional integral of order *α* associated to ${}^{C}D_{t}^{\alpha}.$

In order to conveniently solve the combined fractional and fractal system [(24)](#eq0024){ref-type="disp-formula"}, it is important to associate it with the following initial conditions:$$S_{p}\left( 0 \right) = \widetilde{S_{p}}\left( S_{p} \right),\mspace{6mu} I_{c}\left( 0 \right) = \widetilde{I_{c}}\left( I_{c} \right),\mspace{6mu} S_{r}\left( 0 \right) = \widetilde{S_{r}}\left( S_{r} \right),\mspace{6mu} I_{r}\left( 0 \right) = \widetilde{I_{r}}\left( I_{r} \right).$$

We now transform the system [(24)](#eq0024){ref-type="disp-formula"}-[(27)](#eq0027){ref-type="disp-formula"} so that it takes a compact form of the Legendre wavelets approach as described in [@bib0019], [@bib0020]. So consider$$\left\{ \begin{array}{l}
{{}^{C}D_{t}^{\alpha}\left( S_{p}\left( t \right) \right) = \mspace{6mu}^{T}M_{m}^{1}\Psi_{m}\left( t \right),} \\
{{}^{C}D_{t}^{\alpha}\left( I_{c}\left( t \right) \right) = \mspace{6mu}^{T}M_{m}^{2}\Psi_{m}\left( t \right),} \\
{{}^{C}D_{t}^{\alpha}\left( S_{r}\left( t \right) \right) = \mspace{6mu}^{T}M_{m}^{3}\Psi_{m}\left( t \right)} \\
{{}^{C}D_{t}^{\alpha}\left( I_{r}\left( t \right) \right) = \mspace{6mu}^{T}M_{m}^{4}\Psi_{m}\left( t \right).} \\
\end{array} \right.$$Here Ψ~*m*~(*t*) is the matrix whose elements define the Legendre wavelets given as$$\psi_{nm}\left( t \right) = \begin{cases}
{2^{k/2}\sqrt{2m + 1}L_{m}^{*}\left( 2^{k}t - n \right){),\mspace{6mu}\mspace{6mu}}} & {\text{if}\mspace{6mu}\mspace{6mu} t \in \left\lbrack {\frac{n}{2^{k}},\frac{n + 1}{2^{k}}} \right\rbrack;} \\
{0,\mspace{6mu}\mspace{6mu}} & {\text{elsewhere}.} \\
\end{cases}$$with $L_{m}^{*}$ the shifted Legendre polynomial defined on \[0, 1\] as $L_{m}^{*}\left( t \right) = L_{m}\left( 2t - 1 \right),\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( L_{m}\left( 2t - 1 \right) \right)_{m}$ being the family$$\begin{array}{rcl}
L_{0} & = & {1,\mspace{6mu} L_{1} = x,\mspace{6mu}\mspace{6mu} L_{m + 1}\left( x \right) = \frac{1 + 2m}{m + 1}xL_{m}\left( x \right) - \frac{m}{1 + m}L_{m - 1}\left( x \right),} \\
m & = & {1,2,\cdots.} \\
\end{array}$$ ^*T*^ *M* ^1^, ^*T*^ *M* ^2^, ^*T*^3 and ^*T*^ *M* ^4^ are the transpose of the matrices *M* ^1^, *M* ^2^, *M* ^3^ and *M* ^4^ respectively. Associating the initial conditions yields$$\left\{ \begin{array}{l}
{S_{p}\left( t \right) \approx \;^{T}M_{m}^{1}Q_{m \times m}^{\alpha}\Psi_{m}\left( t \right) + \widetilde{S_{p}},} \\
{I_{c}\left( t \right) \approx \;^{T}M_{m}^{2}Q_{m \times m}^{\alpha}\Psi_{m}\left( t \right) + \widetilde{I_{c}},} \\
{S_{r}\left( t \right) \approx \;^{T}M_{m}^{3}Q_{m \times m}^{\alpha}\Psi_{m}\left( t \right) + \widetilde{S_{r}}} \\
{I_{r}\left( t \right) \approx \;^{T}M_{m}^{4}Q_{m \times m}^{\alpha}\Psi_{m}\left( t \right) + \widetilde{I_{r}},} \\
\end{array} \right.$$where $Q_{m \times m}^{\alpha}$ is the Legendre operational matrix of integration and the subscript *m* denotes its dimension. We know that [@bib0019], [@bib0020], Legendre wavelets can be expanded into an *m*-term form as$$\Psi_{m}\left( t \right) = \Upsilon_{m \times m}A_{m}\left( t \right),$$where $A_{m}\left( t \right) =^{T}\left\lbrack a_{1}\left( t \right),a_{2}\left( t \right),\cdots,a_{m}\left( t \right) \right\rbrack$ is the Block Pulse Functions so that$$\begin{array}{r}
{a_{k}\left( t \right) = \begin{cases}
{1,\mspace{6mu}\mspace{6mu}} & {\text{if}\mspace{6mu}\mspace{6mu} t \in \left\lbrack \frac{k - 1}{m},\frac{k}{m} \right\rbrack;} \\
{0,\mspace{6mu}\mspace{6mu}} & {\text{elsewhere}.} \\
\end{cases}} \\
\end{array}$$for each $k = 1,2,\cdots m,$ and Υ the Legendre wavelet matrix$$\Upsilon_{m \times m} = \left\lbrack \Psi_{m}\left( \frac{1}{2m} \right)\Psi_{m}\left( \frac{3}{2m} \right)\cdots\Psi_{m}\left( \frac{2m - 1}{2m} \right) \right\rbrack$$Now the substitution of [(32)](#eq0032){ref-type="disp-formula"} into system [(31)](#eq0031){ref-type="disp-formula"} leads to$$\left\{ \begin{array}{l}
{S_{p}\left( t \right) \approx \;^{T}M_{m}^{1}Q_{m \times m}^{\alpha}\Upsilon_{m \times m}A_{m}\left( t \right) + \left\lbrack {\widetilde{S_{p}}}_{i} \right\rbrack A_{m}\left( t \right),} \\
{I_{c}\left( t \right) \approx \;^{T}M_{m}^{2}Q_{m \times m}^{\alpha}\Upsilon_{m \times m}A_{m}\left( t \right) + \left\lbrack {\widetilde{I_{c}}}_{i} \right\rbrack A_{m}\left( t \right),} \\
{S_{r}\left( t \right) \approx \;^{T}M_{m}^{3}Q_{m \times m}^{\alpha}\Upsilon_{m \times m}A_{m}\left( t \right) + \left\lbrack {\widetilde{S_{r}}}_{i} \right\rbrack A_{m}\left( t \right),} \\
{I_{r}\left( t \right) \approx \;^{T}M_{m}^{4}Q_{m \times m}^{\alpha}\Upsilon_{m \times m}A_{m}\left( t \right) + \left\lbrack {\widetilde{I_{r}}}_{i} \right\rbrack A_{m}\left( t \right).} \\
\end{array} \right.$$Where$$\left\lbrack {\widetilde{S_{p}}}_{i} \right\rbrack = \left\lbrack {\widetilde{S_{p}}}_{1},{\widetilde{S_{p}}}_{2},\cdots,{\widetilde{S_{p}}}_{m} \right\rbrack,\mspace{6mu}\left\lbrack {\widetilde{I_{c}}}_{i} \right\rbrack = \left\lbrack {\widetilde{I_{c}}}_{1},{\widetilde{I_{c}}}_{2},\cdots,{\widetilde{I_{c}}}_{m} \right\rbrack$$ $$\left\lbrack {\widetilde{S_{r}}}_{i} \right\rbrack = \left\lbrack {\widetilde{S_{r}}}_{1},{\widetilde{S_{r}}}_{2},\cdots,{\widetilde{S_{r}}}_{m} \right\rbrack,\mspace{6mu}\left\lbrack {\widetilde{I_{r}}}_{i} \right\rbrack = \left\lbrack {\widetilde{I_{r}}}_{1},{\widetilde{I_{r}}}_{2},\cdots,{\widetilde{I_{r}}}_{m} \right\rbrack.$$Now let$${}^{T}M_{m}^{i}Q_{m \times m}^{\alpha}\Upsilon_{m \times m} = \mathcal{M}_{1 \times m}^{\alpha,i} = \left\lbrack m_{1}^{\alpha,i},m_{2}^{\alpha,i},\cdots,m_{m}^{\alpha,i} \right\rbrack$$Now Using the collocations points $t_{i} = \frac{2i - 1}{2^{k + 1}N},\mspace{6mu}\mspace{6mu} i = 1,2,3,\cdots,m$ $N \in \mathbb{N},$ to disperse *t*, the substitution of [(34)](#eq0034){ref-type="disp-formula"} and [(35)](#eq0035){ref-type="disp-formula"} into system [(24)](#eq0024){ref-type="disp-formula"} and lead to$$\left\{ \begin{array}{l}
{{}^{T}M_{m}^{1}\Upsilon_{m \times m} = \Lambda_{p}\left\lbrack 1,1\cdots,1 \right\rbrack + \gamma\left\lbrack m_{1}^{\alpha,2},m_{2}^{\alpha,2},\cdots,m_{m}^{\alpha,2} \right\rbrack - \left( \lambda_{c} + \mu_{h} \right)} \\
{\left\lbrack m_{1}^{\alpha,1},m_{2}^{\alpha,1},\cdots,m_{m}^{\alpha,1} \right\rbrack + \left\lbrack {\widetilde{S_{p}}}_{1},{\widetilde{S_{p}}}_{2},\cdots,{\widetilde{S_{p}}}_{m} \right\rbrack,} \\
{{}^{T}M_{m}^{2}\Upsilon_{m \times m} = \lambda_{c}\left\lbrack m_{1}^{\alpha,1},m_{2}^{\alpha,1},\cdots,m_{m}^{\alpha,1} \right\rbrack - \left( \mu_{h} + \kappa_{c} + \gamma \right)} \\
{\left\lbrack m_{1}^{\alpha,2},m_{2}^{\alpha,2},\cdots,m_{m}^{\alpha,2} \right\rbrack + \left\lbrack {\widetilde{I_{c}}}_{1},{\widetilde{I_{c}}}_{2},\cdots,{\widetilde{I_{c}}}_{m} \right\rbrack} \\
{{}^{T}M_{m}^{3}\Upsilon_{m \times m} = \Lambda_{r}\left\lbrack 1,1\cdots,1 \right\rbrack - \left( \mu_{c} + \lambda_{r} \right)\left\lbrack m_{1}^{\alpha,3},m_{2}^{\alpha,3},\cdots,m_{m}^{\alpha,3} \right\rbrack} \\
{\left\lbrack {\widetilde{S_{r}}}_{1},{\widetilde{S_{r}}}_{2},\cdots,{\widetilde{S_{r}}}_{m} \right\rbrack} \\
{{}^{T}M_{m}^{4}\Upsilon_{m \times m} = \lambda_{r}\left\lbrack m_{1}^{\alpha,3},m_{2}^{\alpha,3},\cdots,m_{m}^{\alpha,3} \right\rbrack - \mu_{c}\left\lbrack m_{1}^{\alpha,4},m_{2}^{\alpha,4},\cdots,m_{m}^{\alpha,4} \right\rbrack} \\
{\left\lbrack {\widetilde{I_{r}}}_{1},{\widetilde{I_{r}}}_{2},\cdots,{\widetilde{I_{r}}}_{m} \right\rbrack} \\
\end{array} \right.$$Hence we obtain this non-linear system equations with 4*m* unknown coefficients $m_{k}^{\alpha,i},\mspace{6mu}\mspace{6mu} 1 \leq i \leq 4,\mspace{6mu}\mspace{6mu} 1 \leq k \leq m$ which are easily found using Newton iteration method. Then exploiting model [(31)](#eq0031){ref-type="disp-formula"}, leads the south numerical solution (*S~p~*(*t*), *I~c~*(*t*), *S~r~*(*t*), *I~r~*(*t*)).

10. Numerical simulations with some known COVID-19 data {#sec0016}
=======================================================

We can implement in this section the numerical scheme presented above using some data recently given in the literature and summarized in the [Table 2](#tbl0002){ref-type="table"} . The numerical simulations for the behavior of the COVID-19 prevalence for the generalized model [(24)](#eq0024){ref-type="disp-formula"}, performed for certain values of *α* are depicted in [Fig. 16](#fig0016){ref-type="fig"} (a) when $\mu_{c} = 0.059$ and $\mathcal{R}_{c} = 0.64103$ and [Fig. 16](#fig0016){ref-type="fig"} (b) when $\mu_{c} = 0.019$ and $\mathcal{R}_{c} = 5.70103.$ Table 2Description and values for the parameters [@bib0021], [@bib0022].Table 2ParametersDescriptionsEstimated baseline valuesΛ~*p*~Recruitment rate of people population1000Λ~*r*~Recruitment rate of susceptible animals2500*β~c~*Human transmission probability for COVID-19Variable*β~r~*Animal transmission probability for COVID-190.05--1.6*σ*Per capita vector-to-host contact rate$6.33 \times 10^{- 3}$--0.217*μ~h~*Natural death rate in humans0.0131*μ~c~*Natural mortality rate of animals0.035*κ~c~*COVID-19 mortality rate$199 \times 10^{- 4}$*γ*People recovery rate from COVID-190.005ϖHIV People recovery rate from COVID-190.002*θ, ν*Regulation parameters1.0021, 1.002ε, *τ, ξ~hc~*Regulation parameters1,001, 1.001, 1.005,Fig. 16Some predicted COVID-19 prevalence using the generalized model [(24)](#eq0024){ref-type="disp-formula"} for certain values of *α* over 500 days using Table 2 and (a) when $\mu_{c} = 0.059$ and $\mathcal{R}_{c} = 0.64103$ and (b) when $\mu_{c} = 0.019$ and $\mathcal{R}_{c} = 5.70103$.Fig. 16

11. Concluding remarks {#sec0017}
======================

As shown in [Fig. 1](#fig0001){ref-type="fig"}, [Fig. 8](#fig0008){ref-type="fig"} and [Fig. 9](#fig0009){ref-type="fig"} , the numbers of victims and fatalities due to HIV and the new coronavirus remain a fateful scourge around the world. The combination of both will certainly be explosive for most affected countries. We especially think of southern hemisphere countries getting out the summer and moving into the winter season. It is urgent for those countries (like South Africa and Chile) to be alerted while it is still time to react efficiently. Indeed, the world has ignored the first alert made before the pandemic, by the young and now late Chinese doctor Li Wenliang and this is paper serves as a COVID-19 alert for southern hemisphere countries like Chile and South Africa that are moving into the winter season and seeing to be heavily hit by the pandemic. As winter moved to the southern hemisphere, we also observed the epicenter of the new coronavirus shifting there to Brazil, which shares similar features (such as Favellas, townships, poverty, promiscuity) with South Africa and Chile. We have then used a generalized simple mathematical model of HIV-COVID-19 together with graphs, curves and tables to compare the pandemic situation in countries that were once the epicenter of the disease, such as China, Italy, Spain, United Kingdom and United States of America. We managed to show conditions for existence of stable equilibria and of different bifurcation (forward and backward) scenarios for the model. The fractional (generalized) COVID-19 model has been solved numerically and a predicted prevalence for the COVID-19 has been provided. There is a ground to be concerned for southern hemisphere countries now since it happens that all those countries that were once epicenter, were in their winter season during their status of epicenter of the COVID-19 and opted to ease the lockdown only after the peak of the disease was reached. The epicenter is now in Brazil, in full winter season, and we observe its health system and emergency services overcrowded by a large number of COVID-19 patients and deaths. Recent data show an increasing number of infections in Chile and South Africa. The combination with HIV cannot help. Moreover, still far from seeing the disease reaching its peak in the country, South Africa who has just enter into the winter season, opted to reopen the country's activities and schools. This is exactly the opposite of what was observed in western countries. Recall that South Africa stands now as the most COVID-19 affected country in Africa and is it going to be the next epicenter in weeks to come when winter conditions favorable to the spread of the new coronavirus will be comfily installed? The answer is certainly affirmative seeing the social conditions in townships all over the country. The country has however started imposing social distanciation, wearing a face mask in public services, hiring of more health workers and targeted community tests. Will this be enough, as the country chose to reopen most of it economic sectors as from the 1 June 2020, which coincides with beginning of its winter season, we can now ask whether the lockdown that started on the 26 March 2020 was at the right moment. The coming months will tell us. Lastly, another worrying alert is the fact that winter is still going to move to Europe and we may see again the epicenter shifting towards the north, unless a cure or vaccine is found by then. Again the future months will tell us.Fig. 9Illustration of the yearly increase of HIV cases worldwide the WHO [@bib0005].Fig. 9

CRediT authorship contribution statement {#sec0017a}
========================================

**Emile F. Doungmo Goufo:** Conceptualization, Methodology, Writing - original draft. **Yasir Khan:** Data curation. **Qasim Ali Chaudhry:** Writing - original draft, Writing - review & editing, Investigation.

Declaration of Competing Interest
=================================

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

The second author extends their appreciation to the 10.13039/501100004686Deanship of Scientific Research, University of Hafr Al Batin for partially funding this work through the research group project no. (G-108-2020).
